Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
LGC Capital Ltd. Announces Name Change to Elixxer Ltd. MONTRÉAL, July 30, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that the TSX...
EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval MONTREAL, July 24, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) LGC is pleased to...
EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is...
LGC Capital Ltd. Announces Change in Financial Year-End MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing...
Annonce de LGC Capital Ltd. : Tricho-Med a le feu vert de Santé Canada pour cultiver du cannabis à Brownsburg, au Québec MONTRÉAL, 15 juill. 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd...
LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec MONTREAL, July 15, 2019 (GLOBE NEWSWIRE...
LGC Capital Ltd. Announces Amendment to Stock Option Plan MONTRÉAL, June 11, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) announces that it has amended its...
LGC Capital News Release MONTRÉAL, May 31, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) comments on yesterday’s opinion from the...
UPDATE: LGC Capital Ltd. Closes Financing With Arlington Capital and Retains Renmark Financial Communications Inc. MONTRÉAL, May 31, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V:...
LGC Capital Ltd. Closes Financing With Arlington Capital and Retains Renmark Financial Communications Inc. MONTRÉAL, May 31, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG /...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
